Everlab announced that it has raised AU$65 million in Series A funding to expand its preventative and personalized healthcare platform.
The oversubscribed round was led by Airtree Ventures, with participation from global investors including Plural and existing investors Left Lane Capital and b2venture. Angel investors in the round included Australian Test captain Pat Cummins.
Founded in Melbourne in 2023, Everlab is building a preventative healthcare platform designed to help patients manage diagnostics, doctors, specialists, prescriptions, wearable data, and AI-supported care in one place.
The company said the funding marks its evolution into a complete care platform focused on transforming primary care from a system built mainly to treat illness into one designed to prevent it.
Everlab said patients often face fragmented healthcare experiences across disconnected providers, isolated medical records, transactional telehealth visits, and wearable devices that generate insights without enough clinical follow-through. The company’s platform is designed to bring those pieces together into a longitudinal view of a patient’s health.
Everlab’s digital app integrates with more than 1,850 health provider locations, over 180 active clinicians, and more than 30 wearable devices. The platform also processes more than 200,000 health reports per month.
To date, Everlab has completed more than 40,000 consultations and supported over 20,000 individual patients. The company also works with corporate partners, including Boston Consulting Group, BHP, and Bain & Company.
The company said it has processed more than 21 million biomarker test results. More than 25% of members have had findings flagged that were not identified through the existing healthcare system, according to Everlab.
The funding will support Everlab’s move into the global consumer healthcare market, starting with the United Kingdom. The company also plans to use the capital to strengthen its clinical and technology infrastructure and accelerate its international rollout.
Everlab operates across Australia and New Zealand and supports individuals and organizations through preventative healthcare programs. The company’s mission is to maximize healthspan at the lowest lifetime cost by combining diagnostics, clinician-led care, and AI-enabled technology.
KEY QUOTES:
“The existing system is fragmented, handing patients between providers and hoping the information follows. We built Everlab to hold the full picture, surface health blind spots and coordinate what needs to happen next—from targeted screenings to personalized health plans—helping more people live longer, healthier lives.”
Marc Hermann, Co-Founder and CEO of Everlab
“Our patient base reflects the broader Australian population, and earning their trust to hold decades of their health data is the foundation everything else runs on. Our goal is to cut a new path for primary care globally, proving that deep patient engagement and first-class preventative care don’t just improve outcomes, it reduces the lifetime cost of care for everyone.”
Dr. Steven Lu, Chief Medical Officer of Everlab
“The more time we spent with the Everlab team, the more convinced we became that they’re building a generational health business. With a world-class product and growing at a pace we rarely see, they’re already the leader in Australia and we’re backing them to do the same globally.”
John Henderson, Partner at Airtree
“Every company that has tried to own the patient journey has ended up either selling doctor time by the minute or reselling lab tests with thin margins. Everlab is building the layer above both: the system that interprets and coordinates your health data over time rather than capturing a single transaction. The fact that they’ve already proven their model operationally in Australia, at scale, is what convinced me this is the version that genuinely works.”
Carina Namih, Partner at Plural
